» Articles » PMID: 29731800

Sinonasal Teratocarcinosarcoma- A Rare Tumour Not So Rarely Misdiagnosed

Overview
Journal Iran J Pathol
Date 2018 May 8
PMID 29731800
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Sinonasal teratocarcinosarcoma (STCS) is a rare, morphologically heterogeneous and highly aggressive tumour of ambiguous origin. It is characterized by the presence of benign and malignant epithelial, mesenchymal and neuroectodermal components. Because of their rarity and heterogeneity, these lesions are often misdiagnosed, leading to management difficulties. Adequate sampling with a high index of suspicion is needed to diagnose this rare tumour. We reported here a 48-year old man with right nasoethmoidal mass eroding the cribriform plate with intracranial extension. An initial incisional biopsy was performed and a diagnosis of craniopharyngioma was made. Subtotal endoscopic excision of the mass revealed features of STCS. Immunohistochemistry confirmed the same. The patient was subsequently treated with radiotherapy. The histogenesis, histopathological features, immunohistochemistry findings, clinical features and treatment were discussed here. Till date, there are less than 100 cases reported in English literature.

Citing Articles

Sinonasal Teratocarcinosarcoma: A Rare and Highly Aggressive Neoplasm.

Hanif H, Misbah D, Maqsood S, Iftikhar S, Inam Y Cureus. 2023; 15(7):e41396.

PMID: 37546103 PMC: 10401896. DOI: 10.7759/cureus.41396.


Sinonasal teratocarcinosarcoma: a therapeutic dilemma.

Peralta Suarez G, Dibs K, Carrau R, Schoenfield L, Blakaj D, Tinoco G BMJ Case Rep. 2022; 15(11).

PMID: 36428033 PMC: 9703320. DOI: 10.1136/bcr-2022-252429.


Sinonasal teratocarcinosarcoma: a case report and literature review.

Rao Y, Cheng D, Qiu K, Song Y, Zhao Y, Gu D J Int Med Res. 2020; 48(12):300060520971488.

PMID: 33342340 PMC: 7754799. DOI: 10.1177/0300060520971488.


Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis.

Chapurin N, Totten D, Morse J, Khurram M, Louis P, Sinard R Am J Rhinol Allergy. 2020; 35(1):132-141.

PMID: 32954838 PMC: 8258305. DOI: 10.1177/1945892420959585.

References
1.
Smith S, Hessel A, Luna M, Malpica A, Rosenthal D, El-Naggar A . Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch Otolaryngol Head Neck Surg. 2008; 134(6):592-5. DOI: 10.1001/archotol.134.6.592. View

2.
Budrukkar A, Agarwal J, Kane S, Siddha M, Ghosh Laskar S, Pai P . Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J Laryngol Otol. 2010; 124(7):739-43. DOI: 10.1017/S0022215109992866. View

3.
BATSAKIS J, El-Naggar A, Luna M . Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol. 1995; 104(6):496-500. DOI: 10.1177/000348949510400616. View

4.
Kane S, Karpate A, Bal M, Juvekar S, Pai P . Chemotherapy-induced neuronal maturation in sinonasal teratocarcinosarcoma--a unique observation. Head Neck Pathol. 2010; 3(1):31-6. PMC: 2807528. DOI: 10.1007/s12105-008-0094-x. View

5.
Misra P, Husain Q, Svider P, Sanghvi S, Liu J, Eloy J . Management of sinonasal teratocarcinosarcoma: a systematic review. Am J Otolaryngol. 2013; 35(1):5-11. DOI: 10.1016/j.amjoto.2013.04.010. View